{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:32:06Z","timestamp":1759159926930,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05517-3","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T11:14:10Z","timestamp":1756811650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Afebrile vancomycin-induced delayed hypersensitivity suggestive of incomplete drug rash with eosinophilia and systemic symptoms syndrome: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Chien-Hung","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Chuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Lan","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4522-8423","authenticated-orcid":false,"given":"Kun-Jing","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"issue":"4","key":"5517_CR1","first-page":"694","volume":"19","author":"FR Bruniera","year":"2015","unstructured":"Bruniera FR, Ferreira FM, Saviolli LR, Bacci MR, Feder D, da Luz Gon\u00e7alves Pedreira M, et al. The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci. 2015;19(4):694\u2013700.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"5517_CR2","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir034","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285\u201392.","journal-title":"Clin Infect Dis"},{"issue":"2021","key":"5517_CR3","first-page":"9932425","volume":"4","author":"JA Zadroga","year":"2021","unstructured":"Zadroga JA, Mogulla V, Grant C, Jevtic D, Virata A, Dumic I. The many faces of purpura: vancomycin-induced leukocytoclastic vasculitis. Case Rep Infect Dis. 2021;4(2021):9932425.","journal-title":"Case Rep Infect Dis"},{"issue":"5","key":"5517_CR4","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/ccr3.2039","volume":"7","author":"L Visentainer","year":"2019","unstructured":"Visentainer L, Massuda JY, Cintra ML, Magalh\u00e3es RF. Vancomycin-induced linear IgA bullous dermatosis (LABD)-an atypical presentation. Clin Case Rep. 2019;7(5):1091\u20133.","journal-title":"Clin Case Rep"},{"issue":"3","key":"5517_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00228-020-03005-9","volume":"77","author":"S Sharifzadeh","year":"2021","unstructured":"Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol. 2021;77(3):275\u201389.","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"5517_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.7326\/0003-4819-147-7-200710020-00006","volume":"147","author":"R Chou","year":"2007","unstructured":"Chou R, Qaseem A, Snow V, Casey D, Cross JT Jr, Shekelle P, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med. 2007;147(7):478\u201391.","journal-title":"Ann Intern Med"},{"key":"5517_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jclinane.2017.08.030","volume":"43","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Xu H, Zhang Y, Li W, Yang Y, Han T, et al. Nonsteroidal anti-inflammatory drugs for postoperative pain control after lumbar spine surgery: a meta-analysis of randomized controlled trials. J Clin Anesth. 2017;43:84\u20139.","journal-title":"J Clin Anesth"},{"issue":"3-S","key":"5517_CR8","first-page":"44","volume":"90","author":"F Franceschini","year":"2019","unstructured":"Franceschini F, Bottau P, Caimmi S, Cardinale F, Crisafulli G, Liotti L, et al. Mechanisms of hypersensitivity reactions induced by drugs. Acta Biomed. 2019;90(3-S):44\u201351.","journal-title":"Acta Biomed"},{"issue":"5","key":"5517_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-2125.2010.03703.x","volume":"71","author":"MR Ardern-Jones","year":"2011","unstructured":"Ardern-Jones MR, Friedmann PS. Skin manifestations of drug allergy. Br J Clin Pharmacol. 2011;71(5):672\u201383.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"5517_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.iac.2022.10.005","volume":"43","author":"RG Wilkerson","year":"2023","unstructured":"Wilkerson RG. Drug hypersensitivity reactions. Immunol Allergy Clin North Am. 2023;43(3):473\u201389.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"8","key":"5517_CR11","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/cid\/cit949","volume":"58","author":"DP Legendre","year":"2014","unstructured":"Legendre DP, Muzny CA, Marshall GD, Swiatlo E. Antibiotic hypersensitivity reactions and approaches to desensitization. Clin Infect Dis. 2014;58(8):1140\u20138.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5517_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.anai.2016.03.030","volume":"116","author":"JS Minhas","year":"2016","unstructured":"Minhas JS, Wickner PG, Long AA, Banerji A, Blumenthal KG. Immune-mediated reactions to vancomycin: a systematic case review and analysis. Ann Allergy Asthma Immunol. 2016;116(6):544\u201353.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"5517_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy8020070","volume":"8","author":"V Huang","year":"2020","unstructured":"Huang V, Clayton NA, Welker KH. Glycopeptide hypersensitivity and adverse reactions. Pharmacy (Basel). 2020;8(2): 70.","journal-title":"Pharmacy (Basel)"},{"issue":"3","key":"5517_CR14","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/oxfordjournals.jac.a020861","volume":"39","author":"TM Korman","year":"1997","unstructured":"Korman TM, Turnidge JD, Grayson ML. Risk factors for adverse cutaneous reactions associated with intravenous vancomycin. J Antimicrob Chemother. 1997;39(3):371\u201381.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"5517_CR15","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/j.1875-9114.1997.tb03104.x","volume":"17","author":"PE Marik","year":"1997","unstructured":"Marik PE, Ferris N. Delayed hypersensitivity reaction to vancomycin. Pharmacotherapy. 1997;17(6):1341\u20134.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"5517_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/cc1871","volume":"7","author":"S Sivagnanam","year":"2003","unstructured":"Sivagnanam S, Deleu D. Red man syndrome. Crit Care. 2003;7(2):119\u201320.","journal-title":"Crit Care"},{"issue":"1","key":"5517_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.mcna.2019.09.003","volume":"104","author":"MS Dykewicz","year":"2020","unstructured":"Dykewicz MS, Lam JK. Drug hypersensitivity reactions. Med Clin North Am. 2020;104(1):109\u201328.","journal-title":"Med Clin North Am"},{"issue":"3","key":"5517_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2022.100673","volume":"16","author":"AM Calle","year":"2023","unstructured":"Calle AM, Aguirre N, Ardila JC, Cardona VR. DRESS syndrome: a literature review and treatment algorithm. World Allergy Organ J. 2023;16(3): 100673.","journal-title":"World Allergy Organ J"},{"issue":"1","key":"5517_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2230.2010.03967.x","volume":"36","author":"SA Walsh","year":"2011","unstructured":"Walsh SA, Creamer D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol. 2011;36(1):6\u201311.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"5517_CR20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/ijms18061243","volume":"18","author":"YT Cho","year":"2017","unstructured":"Cho YT, Yang CW, Chu CY. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci. 2017;18(6):1243.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5517_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/ijd.IJD_582_17","volume":"63","author":"A De","year":"2018","unstructured":"De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug reaction with eosinophilia and systemic symptoms: an update and review of recent literature. Indian J Dermatol. 2018;63(1):30\u201340.","journal-title":"Indian J Dermatol"},{"issue":"8","key":"5517_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-230077","volume":"12","author":"V Cabrera Hernandez","year":"2019","unstructured":"Cabrera Hernandez V, Gonzalez Afonso M, Callero Viera A, Martin-Fernandez Martin L. Symmetrical drug-related intertriginous and flexural exanthema due to clindamycin. BMJ Case Rep. 2019;12(8): e230077.","journal-title":"BMJ Case Rep"},{"issue":"1","key":"5517_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jaad.2019.02.002","volume":"81","author":"LM Madigan","year":"2019","unstructured":"Madigan LM, Fox LP. Vancomycin-associated drug-induced hypersensitivity syndrome. J Am Acad Dermatol. 2019;81(1):123\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"5517_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"5517_CR25","first-page":"315","volume":"27","author":"S Lee","year":"2023","unstructured":"Lee S, Kim HJ, Kim JH, Kim TK, Kang CN, Lee JH, et al. Evaluation of the efficacy and safety of NVP-1203 and aceclofenac in patients with acute low back pain and muscle spasm: a randomized, double-blind, active-controlled, parallel, multicenter, phase 3 clinical trial. Eur Rev Med Pharmacol Sci. 2023;27(1):315\u201324.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05517-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05517-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05517-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:24:53Z","timestamp":1757478293000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05517-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5517"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05517-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"3 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Cathay General Hospital (CGH-P109072).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"439"}}